The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Open accessAbstract
We assessed whether epigenetic histone posttranslational modifications are associated with the prolonged beneficial effects (metabolic memory) of intensive versus conventional therapy during the Diabetes Control and Complications Trial (DCCT) on the progression of microvascular outcomes in the long-term Epidemiology of Diabetes Interventions and Complications (EDIC) study. We performed chromatin immunoprecipitation linked to promoter tiling arrays to profile H3 lysine-9 acetylation (H3K9Ac), H3 lysine-4 trimethylation (H3K4Me3), and H3K9Me2 in blood monocytes and lymphocytes obtained from 30 DCCT conventional treatment group subjects (case subjects: mean DCCT HbA1c level >9.1% [76 mmol/mol] and progression of retinopathy or nephropathy by EDIC year 10 of follow-up) versus 30 DCCT intensive treatment subjects (control subjects: mean DCCT HbA1c level <7.3% [56 mmol/mol] and without progression of retinopathy or nephropathy). Monocytes from case subjects had statistically greater numbers of promoter regions with enrichment in H3K9Ac (active chromatin mark) compared with control subjects (P = 0.0096). Among the patients in the two groups combined, monocyte H3K9Ac was significantly associated with the mean HbA1c level during the DCCT and EDIC (each P < 2.2E-16). Of note, the top 38 case hyperacetylated promoters (P < 0.05) included >15 genes related to the nuclear factor-κB inflammatory pathway and were enriched in genes related to diabetes complications. These results suggest an association between HbA1c level and H3K9Ac, and a possible epigenetic explanation for metabolic memory in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
DNA Methylation and Gene Function
Razin, A., & Riggs, A. D. (1980) · Science · doi:10.1126/science.6254144 · Cited by 2,071
Self-citationThe diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Self-citationMolecular Signals of Epigenetic States
Bonasio, R., Tu, S., & Reinberg, D. (2010) · Science · doi:10.1126/science.1191078 · Cited by 912
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602
Diabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 597
Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., & Natarajan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803623105 · Cited by 412
Self-citationMiao, F., Gonzalo, I. G., Lanting, L., & Natarajan, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311786200 · Cited by 374
Self-citationCirculating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Self-citationBieda, M., Xu, X., Singer, M. A., Green, R., & Farnham, P. J. (2006) · Genome Research · doi:10.1101/gr.4887606 · Cited by 307
Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes
Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P. K., Placha, G., Canani, L. H., Bochenski, J., et al. (2009) · Diabetes · doi:10.2337/db08-1514 · Cited by 291
Self-citationNew Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Self-citationCleary, P. A., Orchard, T. J., Genuth, S., Wong, N. D., Detrano, R., Backlund, J.-Y. C., Zinman, B., Jacobson, A., Sun, W., Lachin, J. M., et al. (2006) · Diabetes · doi:10.2337/db06-0653 · Cited by 264
Self-citationChalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263
Miao, F., Smith, D. D., Zhang, L., Min, A., Feng, W., & Natarajan, R. (2008) · Diabetes · doi:10.2337/db08-0645 · Cited by 247
Self-citationTrxG and PcG Proteins but Not Methylated Histones Remain Associated with DNA through Replication
Petruk, S., Sedkov, Y., Johnston, D. M., Hodgson, J. W., Black, K. L., Kovermann, S. K., Beck, S., Canaani, E., Brock, H. W., & Mazo, A. (2012) · Cell · doi:10.1016/j.cell.2012.06.046 · Cited by 246
Epigenetic phenomena linked to diabetic complications
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.188 · Cited by 239
Epigenetic Histone Methylation Modulates Fibrotic Gene Expression
Sun, G., Reddy, M. A., Yuan, H., Lanting, L., Kato, M., & Natarajan, R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060633 · Cited by 238
Self-citationThomas-Chollier, M., Hufton, A., Heinig, M., O'Keeffe, S., Masri, N. E., Roider, H. G., Manke, T., & Vingron, M. (2011) · Nature Protocols · doi:10.1038/nprot.2011.409 · Cited by 230
Ko, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
Epigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Zhong, Q., & Kowluru, R. A. (2011) · Diabetes · doi:10.2337/db10-0133 · Cited by 210
Epigenetic mechanisms in diabetic vascular complications
Reddy, M. A., & Natarajan, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr024 · Cited by 199
Self-citationMiao, F., Wu, X., Zhang, L., Yuan, Y.-C., Riggs, A. D., & Natarajan, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609446200 · Cited by 182
Self-citationYun, J.-M., Jialal, I., & Devaraj, S. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.014 · Cited by 182
Zhong, Q., & Kowluru, R. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22644 · Cited by 178
Yuan, H., Reddy, M. A., Sun, G., Lanting, L. L., Wang, M., Kato, M. V., & Natarajan, R. D. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00523.2012 · Cited by 150
Self-citationGENUTH, S. M. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.34 · Cited by 144
Self-citationEpigenetics: deciphering its role in diabetes and its chronic complications
Villeneuve, L. M., Reddy, M. A., & Natarajan, R. D. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05497.x · Cited by 131
Self-citationAcetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins
Kadiyala, C. S. R., Zheng, L., Du, Y., Yohannes, E., Kao, H., Miyagi, M., & Kern, T. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375204 · Cited by 123
Profiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes
Miao, F., Chen, Z., Zhang, L., Liu, Z., Wu, X., Yuan, Y., & Natarajan, R. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330373 · Cited by 114
Self-citationPezzolesi, M. G., Katavetin, P., Kure, M., Poznik, G. D., SKUPIEN, J. K., Mychaleckyj, J. C., Rich, S. S., Warram, J. H., & Królewski, A. S. (2009) · Diabetes · doi:10.2337/db09-0641 · Cited by 109
Proliferative Diabetic Retinopathy
Shah, K. B., & Han, D. P. (2004) · International Ophthalmology Clinics · doi:10.1097/00004397-200404440-00007 · Cited by 95
Chan, P.-S., Kanwar, M., & Kowluru, R. A. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.10.002 · Cited by 87
Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Cleary, P. A., Klein, R. L., & Virella, G. (2013) · Diabetes Care · doi:10.2337/dc12-2521 · Cited by 82
Self-citationGene Expression Differences in Skin Fibroblasts in Identical Twins Discordant for Type 1 Diabetes
Caramori, M. L., Kim, Y., Moore, J. H., Rich, S. S., Mychaleckyj, J. C., Kikyo, N., & Mauer, M. S. (2012) · Diabetes · doi:10.2337/db11-0617 · Cited by 34
Miao, F., Chen, Z., Zhang, L., Wang, J., Gao, H., Wu, X., & Natarajan, R. D. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00001.2013 · Cited by 32
Self-citationUsing epigenetic mechanisms to understand the impact of common disease causing alleles
Leung, A., Schones, D. E., & Natarajan, R. D. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.004 · Cited by 24
Self-citation
Cited by
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Self-citationDiabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Das, A., McGuire, P. G., & Rangasamy, S. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.03.024 · Cited by 545
Epigenetic mechanisms in diabetic complications and metabolic memory
Reddy, M. A., Zhang, E., & Natarajan, R. (2015) · Diabetologia · doi:10.1007/s00125-014-3462-y · Cited by 496
Self-citationMolecular pathways that drive diabetic kidney disease
Mohandes, S., Doke, T., Hu, H., Mukhi, D., Dhillon, P., & Susztak, K. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165654 · Cited by 341
Metadata
- Authors
- Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., Lorenzi, G., Kolterman, O., Sun, W., Lachin, J. M., Natarajan, R., & the DCCT/EDIC Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-04-12
- Volume
- 63
- Issue
- 5
- Pages
- 1748-1762
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2166212677
- Cited by
- 253
- References
- 52
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.